All lobbying filings

KYLE HOUSE GROUP

KYLE HOUSE GROUP filed a Q2 report for US PHARMACOPEIA on July 20, 2026, reporting $20,000 in lobbying income.

Lobbying for US PHARMACOPEIA · Pharmaceutical manufacturing

All filings by KYLE HOUSE GROUP · Everything US PHARMACOPEIA has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

JULIAN FLEISCHMAN

Previously held: Senior Legislative Assistant, Rep. Peter Meijer; Legislative Assistant, Rep. Briab Mast

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Foreign Relations

Education and advocacy in support of global health, global medical supply chains, and quality assurance programs. H.R. 8595, the National Security, Department of State, and Related Programs Appropriations Act, 2027

Health Issues

Bills named in this filing 1

H.R. 8595
National Security, Department of State, and Related Programs Appropriations Act, 2027

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.